Suppr超能文献

足月胎膜早破引产;缩宫素与舌下含服米索前列醇对比;一项随机临床试验

Induction of labour in term premature rupture of membranes; oxytocin versus sublingual misoprostol; a randomised clinical trial.

作者信息

Pourali Leila, Saghafi Nafiseh, Eslami Hasan Abadi Saeed, Tara Fatemeh, Vatanchi Atieh Mohamadzadeh, Motamedi Elham

机构信息

a Department of Obstetrics and Gynecology, Faculty of Medicine , Mashhad University of Medical Sciences , Mashhad , Iran.

b Department of Medical Informatics, Faculty of Medicine , Mashhad University of Medical Sciences , Mashhad , Iran.

出版信息

J Obstet Gynaecol. 2018 Feb;38(2):167-171. doi: 10.1080/01443615.2017.1329284. Epub 2017 Aug 8.

Abstract

Premature rupture of the membranes (PROM) occurs in about 8-10% of pregnancies and its most important complication is chorioamnionitis, so labour induction has an important role in this situation. This study was performed to compare oxytocin and sublingual Misoprostol for labour induction in PROM cases with term pregnancy. A total of 270 pregnant women who had spontaneous rupture of membrane and unripe cervix were enrolled. The first group underwent Oxytocin infusion according to low-dose standard protocol and the second group received 25 μg sublingual Misoprostol every 4 h. Time interval from induction to the beginning of active phase of labour was similar in both groups. Second stage of labour was significantly shorter in misoprostol group (p < .05). Although, some maternal side-effects were significantly higher in misoprostol group (p < .001), but 5 minute Apgar score was significantly better in this group. In conclusion, sublingual misoprostol was associated with better neonatal outcomes was more effective than oxytocin for labour induction in PROM cases. Impact statement What is already known on this subject: PROM occurs in about 8-10% of pregnancies; about 60% of these cases are term pregnancies. Most experts recommend early induction of labour in term PROM cases with an eye towards avoiding increased morbidity and mortality. Oxytocin is the most frequently used agent that is administered intravenously for the purpose of labour induction. Misoprostol is an alternative to oxytocin and is simpler to use, as it is administered via the oral, buccal, sublingual, rectal and vaginal routes rather than intravenously. What do the results of this study add: Time interval from induction to the beginning of active phase of labour was similar in both groups. Second stage of labour was significantly shorter in the misoprostol group. Although, some maternal side-effects were significantly higher in misoprostol group, the 5 minute Apgar score was significantly better in this group. What are the implications of these finding for clinical practice and/or further research: Sublingual misoprostol for induction of labour in PROM cases is more effective than oxytocin and its neonatal outcomes are better. Due to its easy prescription and better labour outcomes, sub lingual misoprostol may be a better choice for labour induction in PROM cases.

摘要

胎膜早破(PROM)在约8%-10%的妊娠中发生,其最重要的并发症是绒毛膜羊膜炎,因此引产在这种情况下具有重要作用。本研究旨在比较缩宫素和舌下含服米索前列醇在足月妊娠胎膜早破病例中的引产效果。共纳入270例胎膜自然破裂且宫颈未成熟的孕妇。第一组按照低剂量标准方案进行缩宫素静脉滴注,第二组每4小时舌下含服25μg米索前列醇。两组从引产到产程活跃期开始的时间间隔相似。米索前列醇组第二产程明显更短(p<0.05)。虽然米索前列醇组一些母体副作用明显更高(p<0.001),但该组5分钟阿氏评分明显更好。总之,在胎膜早破病例中,舌下含服米索前列醇引产效果优于缩宫素,且新生儿结局更好。影响声明关于该主题已有的知识:胎膜早破在约8%-10%的妊娠中发生;其中约60%为足月妊娠。大多数专家建议对足月胎膜早破病例尽早引产,以避免发病率和死亡率增加。缩宫素是最常用于静脉引产的药物。米索前列醇是缩宫素的替代药物,使用更简便,因为它通过口服、颊部、舌下、直肠和阴道途径给药,而非静脉给药。本研究结果补充了什么:两组从引产到产程活跃期开始的时间间隔相似。米索前列醇组第二产程明显更短。虽然米索前列醇组一些母体副作用明显更高,但该组5分钟阿氏评分明显更好。这些发现对临床实践和/或进一步研究有何意义:在胎膜早破病例中,舌下含服米索前列醇引产比缩宫素更有效,且新生儿结局更好。由于其易于处方且引产效果更好,舌下含服米索前列醇可能是胎膜早破病例引产的更好选择。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验